Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Tonghua Dongbao Pharmaceutical Co Ltd cash flow reinvestment rate. Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow Reinvestment Rate of 2.39x as of September 2025, reinvesting CN¥150.58 Million (capex CN¥150.58 Million ) from operating cash flow of CN¥62.99 Million. Explore 600867 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tonghua Dongbao Pharmaceutical Co Ltd (2000–2025)
Cash flow reinvestment rate of Tonghua Dongbao Pharmaceutical Co Ltd from 2000 to 2025. Historical reinvestment intensity for Tonghua Dongbao Pharmaceutical Co Ltd across 25 annual periods. Explore capital reinvestment ratio of Tonghua Dongbao Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2000–2025)
Tonghua Dongbao Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2000 to 2025. Year-by-year capital reinvestment analysis for Tonghua Dongbao Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600867 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.64x | CN¥1.82 Billion | CN¥689.23 Million | CN¥517.69 Million | ▲ +91.0% |
| 2024 | 1.38x | CN¥635.44 Million | CN¥459.74 Million | CN¥568.73 Million | ▲ +63.3% |
| 2023 | 0.85x | CN¥729.22 Million | CN¥861.52 Million | CN¥348.13 Million | ▼ -44.2% |
| 2022 | 1.52x | CN¥1.31 Billion | CN¥863.09 Million | CN¥491.63 Million | ▲ +50.2% |
| 2021 | 1.01x | CN¥1.15 Billion | CN¥1.13 Billion | CN¥600.75 Million | ▲ +91.2% |
| 2020 | 0.53x | CN¥629.59 Million | CN¥1.19 Billion | CN¥479.59 Million | ▲ +46.2% |
| 2019 | 0.36x | CN¥416.13 Million | CN¥1.15 Billion | CN¥293.13 Million | ▼ -59.6% |
| 2018 | 0.89x | CN¥784.07 Million | CN¥876.94 Million | CN¥773.07 Million | ▲ +255.9% |
| 2017 | 0.25x | CN¥241.50 Million | CN¥961.19 Million | CN¥185.50 Million | ▼ -85.4% |
| 2016 | 1.72x | CN¥1.25 Billion | CN¥725.76 Million | CN¥411.53 Million | ▼ -12.1% |
| 2015 | 1.96x | CN¥576.63 Million | CN¥294.58 Million | CN¥400.09 Million | ▲ +279.9% |
| 2014 | 0.52x | CN¥106.08 Million | CN¥205.89 Million | CN¥106.08 Million | ▼ -40.2% |
| 2013 | 0.86x | CN¥190.36 Million | CN¥221.06 Million | CN¥190.36 Million | ▼ -30.8% |
| 2012 | 1.24x | CN¥241.83 Million | CN¥194.32 Million | CN¥241.83 Million | ▲ +174.7% |
| 2010 | 0.45x | CN¥72.66 Million | CN¥160.40 Million | CN¥72.66 Million | ▼ -4.8% |
| 2009 | 0.48x | CN¥79.07 Million | CN¥166.20 Million | CN¥79.07 Million | ▼ -22.5% |
| 2008 | 0.61x | CN¥56.67 Million | CN¥92.31 Million | CN¥56.67 Million | ▼ -71.3% |
| 2007 | 2.14x | CN¥258.34 Million | CN¥120.94 Million | CN¥258.34 Million | ▲ +17.6% |
| 2006 | 1.82x | CN¥286.90 Million | CN¥158.00 Million | CN¥286.90 Million | ▲ +40.3% |
| 2005 | 1.29x | CN¥119.38 Million | CN¥92.23 Million | CN¥119.38 Million | ▼ -65.3% |
| 2004 | 3.73x | CN¥49.08 Million | CN¥13.17 Million | CN¥49.08 Million | ▲ +193.0% |
| 2003 | 1.27x | CN¥57.90 Million | CN¥45.51 Million | CN¥57.90 Million | ▼ -54.5% |
| 2002 | 2.79x | CN¥89.41 Million | CN¥31.99 Million | CN¥89.41 Million | ▲ +270.9% |
| 2001 | 0.75x | CN¥88.69 Million | CN¥117.73 Million | CN¥88.69 Million | ▼ -58.2% |
| 2000 | 1.80x | CN¥52.46 Million | CN¥29.12 Million | CN¥52.46 Million | — |